CSD-18544-12330
4 vaccinations
2 coded responses
32 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 114 / NY
- Registered
- 2021-08-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-09
Dose 1 — Pfizer-BioNTech
-
2021-08-17
Registered in v-safe
- 2021-08-17
- 2021-08-23
-
2021-08-30
Dose 2 — Pfizer-BioNTech
- 2021-08-30
-
2021-08-31
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-09-01
- 2021-09-02
- 2021-09-03
- 2021-09-04
- 2021-09-05
- 2021-09-06
- 2021-09-13
- 2021-09-20
- 2021-09-27
- 2021-10-04
- 2021-10-11
- 2021-11-29
-
2022-02-16
Dose 3 — Pfizer-BioNTech
- 2022-02-28
- 2022-02-28
- 2022-03-02
- 2022-03-09
- 2022-03-16
- 2022-03-23
- 2022-03-30
- 2022-05-18
- 2022-08-17
-
2022-09-29
Dose 4 — Pfizer-BioNTech
- 2022-10-14
-
2022-10-20
Survey response — day 21, dose 4MedDRA: Fatigue, Headache, Nausea, Pyrexia — Feeling: Poor · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Headache, nausea, fatigue, & feverMedDRA releases: 2024-11 · check-in free text available
-
2022-10-20
Report sent to call center — day 21, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-10-21
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-10-27
- 2022-11-03
- 2022-11-10
-
2022-12-29
Survey response — 3 months, dose 4MedDRA: Abdominal pain upper, Nausea, Vomiting — Feeling: Fair · Be unable to work or attend schoolFree text: Nausea, vomiting, and stomach crampsMedDRA releases: 2024-11 · check-in free text available
- 2023-03-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-09 | Pfizer-BioNTech | No |
| 2 | 2021-08-30 | Pfizer-BioNTech | No |
| 3 | 2022-02-16 | Pfizer-BioNTech | No |
| 4 | 2022-09-29 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 12 — day 21, dose 4
Symptoms: Headache, nausea, fatigue, & fever
Release 12 — 3 months, dose 4
Symptoms: Nausea, vomiting, and stomach cramps
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain upper | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release